155 related articles for article (PubMed ID: 32088190)
1. Quantitative assessment and clinical relevance of VEGFRs-positive tumor cells in refractory brain tumors.
Tamura R; Sato M; Morimoto Y; Ohara K; Kosugi K; Oishi Y; Kuranari Y; Murase M; Yoshida K; Toda M
Exp Mol Pathol; 2020 Jun; 114():104408. PubMed ID: 32088190
[TBL] [Abstract][Full Text] [Related]
2. Expression of VEGF and its receptor genes in intracranial schwannomas.
Uesaka T; Shono T; Suzuki SO; Nakamizo A; Niiro H; Mizoguchi M; Iwaki T; Sasaki T
J Neurooncol; 2007 Jul; 83(3):259-66. PubMed ID: 17570036
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of the estrogen receptor-related antigen (ER-D5) in human intracranial tumors.
Khalid H; Yasunaga A; Kishikawa M; Shibata S
Cancer; 1995 May; 75(10):2571-8. PubMed ID: 7736403
[TBL] [Abstract][Full Text] [Related]
4. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2.
Zhang Z; Neiva KG; Lingen MW; Ellis LM; Nör JE
Cell Death Differ; 2010 Mar; 17(3):499-512. PubMed ID: 19834490
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of VEGF receptors expression on the tumor cells in skull base chordoma.
Morimoto Y; Tamura R; Ohara K; Kosugi K; Oishi Y; Kuranari Y; Yoshida K; Toda M
J Neurooncol; 2019 Aug; 144(1):65-77. PubMed ID: 31240525
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis and angiogenic tyrosine kinase receptor expression in pediatric brain tumors.
Virág J; Kenessey I; Haberler C; Piurkó V; Bálint K; Döme B; Tímár J; Garami M; Hegedűs B
Pathol Oncol Res; 2014 Apr; 20(2):417-26. PubMed ID: 24190638
[TBL] [Abstract][Full Text] [Related]
7. Expression of VEGF and its receptors in different brain tumors.
Huang H; Held-Feindt J; Buhl R; Mehdorn HM; Mentlein R
Neurol Res; 2005 Jun; 27(4):371-7. PubMed ID: 15949234
[TBL] [Abstract][Full Text] [Related]
8. Study of angiogenic signaling pathways in hemangioblastoma.
Pierscianek D; Wolf S; Keyvani K; El Hindy N; Stein KP; Sandalcioglu IE; Sure U; Mueller O; Zhu Y
Neuropathology; 2017 Feb; 37(1):3-11. PubMed ID: 27388534
[TBL] [Abstract][Full Text] [Related]
9. Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: correlation with microvessel density and clinicopathologic features.
La Rosa S; Uccella S; Finzi G; Albarello L; Sessa F; Capella C
Hum Pathol; 2003 Jan; 34(1):18-27. PubMed ID: 12605362
[TBL] [Abstract][Full Text] [Related]
10. VEGFR1 and VEGFR2 in Alzheimer's Disease.
Harris R; Miners JS; Allen S; Love S
J Alzheimers Dis; 2018; 61(2):741-752. PubMed ID: 29226875
[TBL] [Abstract][Full Text] [Related]
11. Expression of vascular endothelial growth factor (VEGF) and its receptors VEGFR1 and VEGFR2 in primary and recurrent WHO grade III meningiomas.
Baumgarten P; Brokinkel B; Zinke J; Zachskorn C; Ebel H; Albert FK; Stummer W; Plate KH; Harter PN; Hasselblatt M; Mittelbronn M
Histol Histopathol; 2013 Sep; 28(9):1157-66. PubMed ID: 23475388
[TBL] [Abstract][Full Text] [Related]
12. The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells.
Atzori MG; Tentori L; Ruffini F; Ceci C; Lisi L; Bonanno E; Scimeca M; Eskilsson E; Daubon T; Miletic H; Ricci Vitiani L; Pallini R; Navarra P; Bjerkvig R; D'Atri S; Lacal PM; Graziani G
J Exp Clin Cancer Res; 2017 Aug; 36(1):106. PubMed ID: 28797294
[TBL] [Abstract][Full Text] [Related]
13. EBV‑LMP1 is involved in vasculogenic mimicry formation via VEGFA/VEGFR1 signaling in nasopharyngeal carcinoma.
Xu S; Bai J; Zhuan Z; Li B; Zhang Z; Wu X; Luo X; Yang L
Oncol Rep; 2018 Jul; 40(1):377-384. PubMed ID: 29749553
[TBL] [Abstract][Full Text] [Related]
14. Expression of vascular endothelial growth factor (VEGF) and its two receptors in diffusely infiltrating astrocytomas and relationship to proliferative activity of tumor cells.
Xiang F; Tanaka J; Takahashi J; Fukuda T
Brain Tumor Pathol; 2001; 18(2):67-71. PubMed ID: 11908876
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of NF2 gene deletion in sporadic schwannomas, meningiomas, and ependymomas by chromogenic in situ hybridization.
Begnami MD; Palau M; Rushing EJ; Santi M; Quezado M
Hum Pathol; 2007 Sep; 38(9):1345-50. PubMed ID: 17509660
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of Vascular Endothelial Growth Factor Receptors 1, 2, 3 in Primary Human Colorectal Carcinoma.
Nasir A; Reising LO; Nedderman DM; Fulford AD; Uhlik MT; Benjamin LE; Schade AE; Holzer TR
Anticancer Res; 2016 Jun; 36(6):2683-96. PubMed ID: 27272777
[TBL] [Abstract][Full Text] [Related]
17. Tumor vessel biology in pediatric intracranial ependymoma.
Wagemakers M; Sie M; Hoving EW; Molema G; de Bont ES; den Dunnen WF
J Neurosurg Pediatr; 2010 Apr; 5(4):335-41. PubMed ID: 20367336
[TBL] [Abstract][Full Text] [Related]
18. Different cascades in the signaling pathway of two vascular endothelial growth factor (VEGF) receptors for the VEGF-mediated murine hepatocellular carcinoma development.
Yoshiji H; Noguchi R; Kuriyama S; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Uemura M; Fukui H
Oncol Rep; 2005 May; 13(5):853-7. PubMed ID: 15809749
[TBL] [Abstract][Full Text] [Related]
19. Suppression of migratory and metastatic pathways via blocking VEGFR1 and VEGFR2.
Sadremomtaz A; Kobarfard F; Mansouri K; Mirzanejad L; Asghari SM
J Recept Signal Transduct Res; 2018; 38(5-6):432-441. PubMed ID: 30929546
[TBL] [Abstract][Full Text] [Related]
20. Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series.
Tamura R; Morimoto Y; Kosugi K; Sato M; Oishi Y; Ueda R; Kikuchi R; Nagashima H; Hikichi T; Noji S; Kawakami Y; Sasaki H; Yoshida K; Toda M
BMC Cancer; 2020 Mar; 20(1):196. PubMed ID: 32164575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
